INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) Stock Price, Quote, News & History

Key Statistics

Open

$54.29

Volume / Avg.

139.00 / 545.00

Day Range

$54.29 - $54.29

52 Wk Range

37.54 - 52.00

Market Cap

P/E Ratio

176.82

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.49

Recent Innovent Biologics, Inc. News

FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting

The

Vandana Singh

FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab

The FDA advisory committee voted against the full approval of Eli Lilly And Co's (NYSE: LLY) lung cancer treatment over concerns that the clinical trial was conducted only in China and that its results did not apply to U.S. patients.

Vandana Singh

Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate

Vandana Singh

Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates

Vandana Singh

Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

10.00B

Investing Cash Flow (TTM)

-6.51B

Financing Cash Flow (TTM)

4.73B

Free Cash Flow (TTM)

9.32B

Capital Expenditure (TTM)

-683.27M

Net Change in Cash (TTM)

8.22B

Valuation Metrics

Enterprise Value

$20.43B

PE Ratio (TTM)

176.82

PE Ratio (FWD)

131.58

PEG Ratio (TTM)

3.16

PS Ratio (TTM)

11.03

PB Ratio (TTM)

7.47

Earnings Yield % (TTM)

0.57%

Earnings Yield % (FWD)

0.76%

EV / EBITDA (TTM)

89.36

Price / EBITDA (TTM)

94.65

Price / Free Cash Flow (TTM)

15.44

Book Value / Share

$6.59

Company Debt

Total Debt

$2.78B

LT Debt

$1.99B

LT Debt Issuance (TTM)

$2.50B

LT Debt Repayment (TTM)

-$2.54B

Total Cash

$17.34B

Debt to Equity

0.15

Issuance of Debt (TTM)

-$38.68M

Repayment of Debt (TTM)

-$2.54B

Key Statistics

Open

$54.29

Volume / Avg.

139.00 / 545.00

Day Range

$54.29 - $54.29

52 Wk Range

37.54 - 52.00

Market Cap

P/E Ratio

176.82

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.49

About

Sector

Health Care

Industry

Biotechnology

Innovent Biologics is one of the leading biotechnology companies in China. Listed on the Hong Kong stock exchange in 2018, Innovent has 12 commercialized oncology products and four commercialized nononcology products as of January 2026, and 34 drugs ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

IVBIY

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

IVBIY

FAQ

How do I buy INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) stock?

You can purchase shares of INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (OTCPK:IVBIY) through any online brokerage.

View our list of the best stock brokerages

Who are INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) competitors?

There are no as such competitors for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc..

What is the forecast, or price target, for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) stock?

There is no analysis for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. to provide a consensus price target.

What is the current price for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY)?

The stock price for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (OTCPK: IVBIY) is $54.29 last updated August 21, 2026 at 12:06 PM EDT.

Does INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) pay a dividend?

There are no upcoming dividends for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc..

When is INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (OTCPK:IVBIY) reporting earnings?

INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. does not have any upcoming earnings scheduled.

Is INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) going to split?

There is no upcoming split for INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc..

What sector and industry does INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. (IVBIY) operate in?

INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.